Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 7/20 | 0.50 |
| ▸ | METAP1 | P53582 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | HRH1 | P35367 | 2/20 | 0.40 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.38 |
| ▸ | S100A4 | P26447 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1567503 | 0.93 | ACHE (0.58) | ACHEMETAP1TSHRHRH1HRH4 | |
| SCHEMBL29850498 | 0.93 | ACHE (0.58) | ACHEMETAP1TSHRHRH1HRH4 | |
| Hydrochloric Acid SCHEMBL6601125 | 0.91 | ACHE (0.56) | ACHEMETAP1TSHRHRH1HRH4 | |
| SCHEMBL10079528 | 0.81 | S100A4 (0.53) | ACHESMN1; SMN2NPC1TP53MAPT | |
| SCHEMBL10412470 | 0.79 | HRH1 (0.43) | ACHEMETAP1TSHRHRH1HRH4 | |
| SCHEMBL9248465 | 0.77 | ACHE (0.53) | ACHEMETAP1TSHRSMN1; SMN2MAPT | |
| SCHEMBL367345 | 0.75 | KDM4E (0.55) | ACHETSHRSMN1; SMN2NPC1MAPT | |
| SCHEMBL9740101 | 0.75 | ACHE (0.50) | ACHEMETAP1TSHRHRH1MAPT | |
| SCHEMBL15670682 | 0.74 | ACHE (0.53) | ACHEMETAP1TSHRHRH1MAPT | |
| Bromide SCHEMBL15903300 | 0.74 | KDM4E (0.54) | ACHETSHRSMN1; SMN2NPC1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230167447-A1 | Compositions for FNIP1/FNIP2 Gene Modulation and Methods Thereof | GENETIC INTELLIGENCE INC (US) | 2023-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230167447-A1 | Compositions for FNIP1/FNIP2 Gene Modulation and Methods Thereof | FNIP1, FN1, TNNC1 | ACHE 3397/4885METAP1 3652/4885TSHR 3697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.